Clinical trial
Preliminary Application and Evaluation of Exhaled Breath Condensate Biomarkers in Combined Allergic Rhinitis and Asthma Syndrome (CARAS)
NCT06573450 is registered in ClinicalTrials.gov with Henan University of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preliminary Application and Evaluation of Exhaled Breath Condensate Biomarkers in Combined Allergic Rhinitis and Asthma Syndrome (CARAS)
- Lead sponsor
- Henan University of Traditional Chinese Medicine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2023
- Completion date
- May 30, 2025
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
combined allergic rhinitis and asthma syndrome